Yersinia enterocolitica, Y. pseudotuberculosis, and Y. pestis have clearly been shown to cause human disease, while characterization of the remaining eight Yersinia species often referred as "Yersinia enterocolitica-like" strains has been more limited. Recently, however, these species thought to be nonpathogenic to humans have been found to possess novel virulence mechanisms, and some of them have been associated with human disease (3, 4, 14, 16, 17) . Among these species, identification of Y. bercovieri, Y. mollaretii, and Y. rohdei is a problem for clinical microbiology laboratories because the widely used commercial identification systems (for example, API 20 E, API Rapid 32 IDE, Micronaut E, and the Vitek GNI Card) do not list these species in their databases and usually misidentify them as Y. enterocolitica (10, 11) . The identification of Yersinia in clinical microbiology laboratories is generally based on the combination of results from these biochemical identification systems and commercially available antisera against pathogenic serotypes of Y. enterocolitica. In addition, a 16S rRNA gene-based PCR assay for identifying and separating Y. enterocolitica isolates of European and American origin has recently been developed (12) . However, this method involves sequencing, which is not easily applicable in most routine clinical microbiology laboratories. In the present study, we provide readers with simple means of recognizing and identifying Y. enterocolitica-like strains, some of which may have pathogenic potential.
In this study, unserotypeable Y. enterocolitica strains (n ϭ 67) isolated and identified by Finnish hospital laboratories were retested at the Enteric Bacteria Laboratory (EBL), National Public Health Institute, with API 20 E (bioMérieux, France) at 30°C and by slide agglutination with antisera against Y. enterocolitica O:3, O:5, O:8, and O:9 (Denka Seiken, Japan). The strains were also biotyped according to Wauters et al. (18) , and 55 strains belonged to biotype (BT) 1A (data not shown). Of the remaining 12 strains, 11 were not biotypeable (at least two reactions diverged from the established biotypes), and one strain (IH 111767) was BT 3 but was unserotypeable (Table 1) . Thus, their identification as Y. enterocolitica strains was considered doubtful. These strains were further tested for fermentation of sorbose and fucose (at 25°C for 24 and 48 h) and on Congo red-magnesium oxalate agar (CR-MOX test) (13 Genotyping was performed using hybridization with a YeO: 3RS probe as described previously (6) . For sequencing, DNA was isolated from bacterial cells by being boiled. Primers (forward, FD1 MOD; and reverse, 533r) were used to amplify the beginning (450 bp) of the 16S rRNA gene sequence (8, 9) . Sequences with the 533r primer were determined with an ABIPrism 310 Genetic Analyzer using BigDye fluorescent terminator chemistry (Applied Biosystems, Warrington, United Kingdom).
API 20 E identified 9 of the 12 doubtful strains as Y. enterocolitica with Ͼ90% certainty (Table 1 (Fig. 1) , but it can be distinguished by a negative pyrazinamidase reaction with biotyping. In this study, the only exception was the strain IH 111767 with a negative pyrazinamidase reaction, placing it to Y. enterocolitica BT 3,  The cross-reactions of the commercial antisera in serotyping are typical of Y. enterocolitica-like strains and Y. enterocolitica BT 1A (1, 19) . In EBL in 2000, the nonserotypeable strains represented about 40% of the incoming Y. enterocolitica strains (7) . Therefore, building the identification of Y. enterocolitica solely on the use of these sera, together with a diagnostic kit like API 20 E, is inadequate. For laboratories that have limited capacity for biotyping, the simplest way to avoid misidentifications is to compare the colony morphology of a API 20 E-iden- The probe YeO:3RS contains a region upstream of the Y. enterocolitica O-antigen cluster, a repeated sequence (RS) that is present in multiple copies in the genome. In our previous study (6) , the RS was shown to be present only in the genome of the "European" pathogenic serotypes (namely, O:3, O:5,27, O:9, O:1, and O:2) of Y. enterocolitica. The sequence was absent from the genomes of other Y. enterocolitica serotypes and Yersinia species, resulting in a weak or incomplete typing pattern of those strains in that study. The current results are in accordance with the previous observations; none of the Y. enterocolitica-like strains were typeable with the probe compared to the complete typing pattern of the "European" pathogenic bioserotypes in this study. The latter strains were also clearly positive by a CR-MOX test (Table 1) .
To summarize, a simple scheme for identification of Y. enterocolitica-like strains is presented. Without accurate identification, already in the primary diagnostics, it is impossible to gain insight into the true clinical significance of Y. enterocolitica-like species. Although the advanced molecular methods are constantly developed, they still may not be available in many routine clinical microbiology laboratories. Therefore, it was interesting to notice how easily the straightforward comparison of the colony morphology of Yersinia isolates can effectively prevent the misidentification of a strain as Y. enterocolitica.
